Graph-based deep learning for integrating single-cell and bulk transcriptomic data to identify clinical cancer subtypes
Briefings in Bioinformatics · 2025
DOI: 10.1093/bib/bbaf467 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2025. Verfasst von Yixin Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Modern Education Technology Center, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin 150080, China. Hauptthemen laut MEDLINE: Deep Learning, Single-Cell Analysis, Neoplasms, Transcriptome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The integration of single-cell RNA sequencing (scRNA-seq) and bulk transcriptomic data has become essential for deciphering the complex heterogeneity of cancer and identifying clinical cancer subtypes. However, the inherent challenges posed by the high dimensionality, sparsity, and noise characteristics of scRNA-seq data have significantly hindered its widespread clinical translation. To address these limitations, we introduce single-cell and bulk transcriptomic graph deep learning, a graph-based deep learning method that synergistically integrates scRNA-seq and bulk transcriptomic data to precisely identify cancer subtypes and predict clinical outcomes. scBGDL constructs sample-specific gene graphs modeling complex gene–gene interactions and cellular relationships. The architecture employs Graph Attention Networks for feature aggregation, MinCutPool layers for dimensionality reduction, and Transformer modules to capture high-order biological dependencies. Independently validated in each of 16 distinct The Cancer Genome Atlas cancer types, scBGDL significantly outperformed existing methods in prognostic accuracy (mean C-index: 0.7060 versus 0.6709 max competitor), demonstrating robustness and generalizability to diverse transcriptional architectures. To demonstrate clinical versatility, we further evaluated scBGDL in three therapeutic contexts using multicenter cohorts: lung adenocarcinoma survival prediction (n = 1099), epithelial ovarian cancer platinum-based chemotherapy response (n = 762), skin cutaneous melanoma immunotherapy outcome (n = 305). scBGDL consistently delivered robust risk stratification (log-rank P < 0.05 across cohorts), identified key driver edges, and uncovered clinically relevant biological interpretations. By enabling multimodal data integration and interpretable biological insights, scBGDL advances precision oncology for prognosis prediction, therapy optimization, and biomarker discovery. The source code for scBGDL model is available online (https://github.com/NEFLab/scBGDL).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Modern Education Technology Center, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin 150080, China.
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Harbin Medical University, 199 Dazhi Street, Nangang District, Harbin 150007, China.
- College of Computer and Control Engineering, Northeast Forestry University, 26 Hexing Road, Xiangfang District, Harbin 150040, China.
ORCID-Profile: Yixin Liu, Guohua Wang, Yuming Zhao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, Y., Zhang, D., Liu, T., Wang, A., Wang, G., & Zhao, Y. (2025). Graph-based deep learning for integrating single-cell and bulk transcriptomic data to identify clinical cancer subtypes. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbaf467
Vancouver
Liu Y, Zhang D, Liu T, Wang A, Wang G, Zhao Y. Graph-based deep learning for integrating single-cell and bulk transcriptomic data to identify clinical cancer subtypes. Briefings in Bioinformatics. 2025. doi:10.1093/bib/bbaf467
BibTeX
@article{Liu2025,
author = {Liu, Yixin and Zhang, Dandan and Liu, Tianyu and Wang, Ao and Wang, Guohua and Zhao, Yuming},
title = {Graph-based deep learning for integrating single-cell and bulk transcriptomic data to identify clinical cancer subtypes},
journal = {Briefings in Bioinformatics},
year = {2025},
doi = {10.1093/bib/bbaf467}
}
EUVIMED